Benzinga's Top Downgrades
March 02, 2015 at 09:13 AM EST
Analysts at Credit Suisse downgraded Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) from Neutral to Underperform. The price target for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.